What is NDC 65162-061?

65162-061 is the product NDC for Ritonavir, Ritonavir 100 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals LLC, NDC labeler code 65162. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ritonavir?

6 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ritonavir NDC 65162-061 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)65162-061Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65162-0061Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65162-061-06	65162006106	60 TABLET in 1 BOTTLE (65162-061-06)Marketed from Sep 21, 2018
65162-061-32	65162006132	360 TABLET in 1 BOTTLE (65162-061-32)Marketed from Sep 21, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ritonavir
Generic name (nonproprietary): ritonavir
Active ingredients: Ritonavir — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals LLCNDC labeler code 65162
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208890
Marketing start: Sep 21, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 1A2 Inducers (Mechanism)Cytochrome P450 2B6 Inducers (Mechanism)Cytochrome P450 2C19 Inducers (Mechanism)Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inducers (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)HIV Protease Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)UDP Glucuronosyltransferases Inducers (Mechanism)
Identifiers: Product ID 65162-061_3ef0739f-9d04-4283-9bcd-fc21099f630cSPL ID 3ef0739f-9d04-4283-9bcd-fc21099f630cSPL set ID a32cb2e3-d4e5-4bbf-9d88-20b2b249e779RxCUI 900575UNII O3J8G9O825UPC 0365162061062
Pharmacologic class: Cytochrome P450 3A Inhibitor; Protease Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465162006106 followed by a unit qualifier and the quantity

Package 65162-0061-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 6, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Ritonavir tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. Ritonavir tablets are HIV protease inhibitors indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65162-061

What is NDC 65162-061?: 65162-061 is the product NDC for Ritonavir, Ritonavir 100 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ritonavir.
What is the active ingredient?: Ritonavir.
Who is the labeler?: Amneal Pharmaceuticals LLC, NDC labeler code 65162. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ritonavir?: 6 other product NDCs are listed under this name. See all Ritonavir NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ritonavir NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ritonavir	Ritonavir 100 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-420	60687-0420-25
Ritonavir	Ritonavir 100 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2610	71335-2610-01
Ritonavir	Ritonavir 100 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-687	65862-0687-0165862-0687-0565862-0687-30+1 more
Ritonavir	Ritonavir 100 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals, Inc.	68071-3898	68071-3898-03
Ritonavir	Ritonavir 100 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-597	31722-0597-1231722-0597-30
Ritonavir	Ritonavir 100 mg/1	TabletOral	Bryant Ranch Prepack	63629-5702	63629-5702-01